Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,012.30
+75.90 (2.58%)
Mar 10, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 366.72 billion as of March 10, 2026. Its market cap has increased by 14.69% in one year.
Market Cap
366.72B
Enterprise Value
359.78B
Revenue
52.02B
Ranking
n/a
PE Ratio
36.16
Stock Price
3,012.30
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 366.72B, an increase of 64,715.00%. That is a compound annual growth rate of 31.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 366.72B | 6.05% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 724.43B |
| Alkem Laboratories | 652.82B |
| Glenmark Pharmaceuticals | 597.59B |
| Laurus Labs | 551.19B |
| Ipca Laboratories | 381.22B |
| Emcure Pharmaceuticals | 288.38B |
| Gland Pharma | 276.38B |
| Wockhardt | 206.24B |